The study conducted at Emory University demonstrated that subjects who received a booster dose of Covaxin (BBV152) six months after getting...

The US firm in a press release said the Phase 3 trial, proposed in the IND, is designed to establish whether the immune response experience...

The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 a...

Under the agreement, Ocugen will have the US rights to the vaccine candidate and will be responsible for clinical development, regulatory a...

Responding to a question on the denial to Covaxin, NITI Aayog member (Health) V K Paul said each country has its own regulatory system whic...

Ocugen in a statement on Thursday announced that as recommended by theFDA,it will pursue submission of a biologics licence application (BLA...

Ocugen said the decision was based on a recommendation from the U.S. Food and Drug Administration (FDA), which also requested more informat...

A bigger-than-expected jump in May consumer prices raised concerns of early policy tightening by the Federal Reserve, while another report ...

The Indian biotech company and Ocugen Inc have entered into a definitive agreement to co-develop, supply, and commercialise Covaxin for the...

Ocugen has submitted key information and data to date including preclinical studies, chemistry, manufacturing, and controls (CMC), and clin...

Stocks that have notched big swings this month include laser-manufacturer MicroVision Inc, a favorite on Reddit’s popular WallStreetBets fo...

The Pennsylvania-based biopharmaceutical firm is partnering with India's Bharat Biotech, a developer of the vaccine, to commercialize the s...

"We have submitted our documentation in Brazil and other countries and await their approval. We plan to export several million doses to Bra...

The companies have entered into a definitive agreement for Covaxin, an advanced stage whole-virion inactivated COVID-19 vaccine candidate, ...

The government also approved the use of a vaccine developed by AstraZeneca and Oxford University which will be the lead vaccine in India's ...

COVAXIN has been developed by Bharat Biotech, a company based in Hyderabad, with backing from the state-run Indian Council of Medical Resea...

As per the letter of intent (LOI), "Ocugen will have US rights to the vaccine candidate and, in collaboration with Bharat Biotech, will be ...